# TradingAgents Debate Record

- Ticker: `MPL.AX`
- Trade date: `2026-07-02`
- Status: completed Codex-visible debate transcript assembled from role outputs

This file is assembled after Codex-session role reports are written. It preserves the completed debate turns and links to the full role files.

## Research Team Debate

### Bull Researcher Round 1 - Opening Case

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\2_research\bull_round_1.md`

## Tool Outputs Used
- Market Analyst: market:MPL.AX:2026-07-02:001 through market:MPL.AX:2026-07-02:004.
- Financial Report Analyst: financial:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:003, financial:MPL.AX:2026-07-02:008.
- News Analyst: news:MPL.AX:2026-07-02:001.

## Strongest Bull Evidence
- The best bull case is available ASX filing sections and market evidence support a reviewable base case, supported by direct filing and earnings-release evidence: financial:MPL.AX:2026-07-02:001 and financial:MPL.AX:2026-07-02:008.
- Market evidence is not ignored: latest close 4.99 is above the 10 EMA, above the 50 SMA, and above the 200 SMA (market:MPL.AX:2026-07-02:001, market:MPL.AX:2026-07-02:004).
- News support comes from news:MPL.AX:2026-07-02:001; social evidence is not counted as independent high-confidence confirmation.

## Falsification Conditions
- Falsified if updated filing evidence contradicts the earnings/segment strength cited above.
- Falsified technically if price loses the 10 EMA at 4.94 and fails to recover, or if MPL.AX breaks materially below the 200 SMA at 4.63.
- Falsified if Research Manager finds the same event is double-counted across News and Sentiment.

## Response To Bear
Bear is right that valuation and trend quality matter. The bull answer is that direct financial evidence remains stronger than retail sentiment, so the risk should limit aggressiveness rather than erase the constructive case.

### Bear Researcher Round 1 - Rebuttal to Bull

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\2_research\bear_round_1.md`

## Tool Outputs Used
- Market Analyst moving-average and MACD evidence: market:MPL.AX:2026-07-02:001, market:MPL.AX:2026-07-02:003, market:MPL.AX:2026-07-02:004, market:MPL.AX:2026-07-02:006.
- Fundamentals and filings: fundamentals:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:012.
- Sentiment source quality records: social:MPL.AX:2026-07-02:001, social:MPL.AX:2026-07-02:002.

## Strongest Bear Evidence
- The strongest bear case is source coverage gaps and technical confirmation risk limit conviction. The table-driven market evidence shows close 4.99, 50 SMA 4.77, 200 SMA 4.63, and MACD 0.06.
- Sentiment is low-confidence retail color, not institution-level confirmation; therefore bullish platform labels should not be over-weighted.
- Risk factors and valuation/timing evidence require a margin of safety rather than a pure growth extrapolation.

## Falsification Conditions
- Falsified if MPL.AX reclaims the key trend levels with MACD improving and filings continue to show durable growth.
- Falsified if Bear relies only on noisy social posts or generic risk text without evidence IDs.

## Response To Bull
Bull's strongest argument is direct earnings and segment evidence. Bear's answer is not that the company is weak; it is that market timing, valuation, and trend evidence limit the immediate reward/risk, especially where social evidence is low-quality.

### Research Manager Decision - Evidence Weighing

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\2_research\manager.md`

## Tool Outputs Used
- Analyst reports for market, sentiment, news, fundamentals, financial report, and industry/theme discovery.
- Debate reports from Bull and Bear researchers.

## Primary Rating Driver
Primary rating driver: sector_metric

Market technicals are treated as a confidence and timing modifier, not as the main investment-rating engine.

## Evidence Winner
Adverse sector-specific metrics outweigh supportive evidence: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only, 2 available / 0 gap-labelled core sections, with membership (financial:MPL.AX:2026-07-02:018) as the clearest adverse/quality reference.

## Structured Evidence Matrix
| Role | Evidence ID | Direction | Materiality | Confidence | Tool output | Weight | Reason | Independence group ID |
|---|---|---|---|---|---|---:|---|---|
| Market Analyst | market:MPL.AX:2026-07-02:001 | positive | high | medium | market snapshot | +1 | Underweight is driven by sector_metric: Adverse sector-specific metrics outweigh supportive evidence: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only, 2 available / 0 gap-labelled core sections, with membership (financial:MPL.AX:2026-07-02:018) as the clearest adverse/quality reference. Market setup is a confidence/timing modifier only: latest close 4.99 is above the 10 EMA (4.94), above the 50 SMA (4.77), and above the 200 SMA (4.63). Trend score +2 changes Trader timing and Research Manager confidence, but it is not the evidence winner. | market:MPL.AX:2026-07-02:trend |
| Financial Report Analyst | financial:MPL.AX:2026-07-02:001 | positive | high | medium | filing section extraction | +2 | ASX document and sector-metric records support financial review with gaps disclosed | event:MPL.AX:2026-07-02:financial-report |
| News Analyst | news:MPL.AX:2026-07-02:001 | positive | medium | medium | article evidence card | +1 | Direct company evidence, not repeated snippet-only headlines | event:MPL.AX:2026-07-02:earnings |
| Sentiment Analyst | social:MPL.AX:2026-07-02:001 | mixed | low | low | social summary | 0 | Retail-only reaction is noisy and not independent fundamental evidence | reaction:MPL.AX:2026-07-02:retail |
| Bear Researcher | fundamentals:MPL.AX:2026-07-02:001 | negative | medium | medium | fundamentals packet | -1 | Valuation/timing risk keeps action from becoming aggressive | risk:MPL.AX:2026-07-02:valuation-trend |

Score calculation / component weights: Sector metric direction mix (5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only), +1 official financial-report sections (2 available / 0 gap-labelled core sections), +2 market setup as timing/confidence modifier (positive across 10 EMA, 50 SMA, and 200 SMA), -1 evidence-gap/source-depth cap, 0 retail sentiment = Underweight driven by sector_metric.

## Role Evidence Weighting
- Financial report / sector metrics: primary evidence group for ASX where available; filing and fundamentals evidence is not counted again through Bull/Bear restatement.
- Market technicals: capped timing/confidence modifier.
- News: contextual event evidence unless a direct material event is identified.
- Sentiment: low-confidence retail reaction with zero standalone decision weight.

## Rating Rationale
**Recommendation**: Underweight

Underweight beats Hold because health_insurers sector metrics include multiple adverse directional readings. Trader still decides whether Sell timing is confirmed. The earnings/news/social style of evidence is grouped by independence ID so repeated role mentions do not become separate support. Rating-vs-rating selection was explicitly considered; social sentiment alone has zero decision weight.

## Rating-vs-Rating Reasoning
1. Why not Buy / Overweight? Buy/Overweight is not selected because adverse metric direction is too prominent (2 adverse versus 1 supportive).
2. Why not Sell / Underweight? Sell is not selected by Research Manager because Sell is reserved for a completed negative investment case; Trader must separately confirm a Sell setup.
3. Which role evidence was decisive? Decisive role evidence is Financial Report Analyst / ASX sector metrics (financial:MPL.AX:2026-07-02:018) plus Fundamentals/Financial section context; Market Analyst (market:MPL.AX:2026-07-02:001, market:MPL.AX:2026-07-02:002, market:MPL.AX:2026-07-02:003, market:MPL.AX:2026-07-02:004) modifies timing; News (news:MPL.AX:2026-07-02:001) is contextual and Sentiment is low weight.
4. Which sector-specific financial metrics mattered? health_insurers metric direction mix: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only. supportive examples: membership (supportive, financial:MPL.AX:2026-07-02:018); adverse examples: premium growth (adverse, financial:MPL.AX:2026-07-02:016); claims ratio (adverse, financial:MPL.AX:2026-07-02:017); mixed/neutral examples: capital adequacy (neutral, financial:MPL.AX:2026-07-02:019); operating profit (neutral, financial:MPL.AX:2026-07-02:020). Highlighted metric: membership is available / supportive via financial:MPL.AX:2026-07-02:018.
5. Which evidence gaps capped confidence? Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-02:001, and medium-confidence extraction depth.
6. How market setup changed the final rating. Market setup is a confidence/timing modifier only: latest close 4.99 is above the 10 EMA (4.94), above the 50 SMA (4.77), and above the 200 SMA (4.63). Trend score +2 changes Trader timing and Research Manager confidence, but it is not the evidence winner.

## Sector Metric Direction Audit
Direction is based on the extracted phrase, supporting sentence, clean value, and comparison basis below, not metric presence alone. Navigation/page-list snippets are downgraded to low-confidence context-only evidence.

| metric_name | extracted_value_or_phrase | clean_metric_value | value_unit | value_context | metric_value_status | association_score | association_reason | table_mapping_confidence | table_mapping_reason | period_reference | comparison_reference | supporting_sentence | comparison_basis | direction | confidence | confidence_reason | evidence_id | table_title | row_label | column_label | cell_value | source_page | current_period_value | prior_period_value | variance_value | variance_percent | raw_row_text |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| premium_growth | r for the 4th year running. Our Live Better rewards members redeemed around $33 million in rewards points this year, through our program which challenges them to take daily actions | unavailable | unavailable | no high-confidence metric-value association | unavailable | 0 | metric label was not found in extracted text | 0 | no table row mapping available | unavailable | unavailable | r for the 4th year running. | period-over-period wording in extracted filing/report phrase | adverse | low | source extractor confidence is low and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:016 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| claims_ratio | .5% to 22.5 cents per share. The key reasons for the movements in the Health Insurance and Medibank Health results, as well as net investment income, are outlined in this report. H | 3.3 | % | dense row parsed before next financial row label | value_extracted | 88 | dense row label matched accepted metric label and value was selected from the parsed metric row before the next row label | 88 | dense metric row isolated before next financial row label | variance_percent | prior_period_value | .5% to 22.5 cents per share. | period-over-period wording in extracted filing/report phrase | adverse | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:017 | unavailable | claims expense (including risk equalisation) (6,814.6) (6,595.8) 3.3% | variance_percent | 3.3% | unavailable | -6814.6 | -6595.8 | unavailable | 3.3 | claims expense (including risk equalisation) (6,814.6) (6,595.8) 3.3% |
| membership | tomers $1.71b total COVID financial support since 2020 $6.6b total claims paid Medibank journey NPS 12.9 (+2.3) average ahm service NPS 48.0 (+2.0) average customer advocacy +27.9k | 3.1 | % | policyholders near 3.1% | value_extracted | 85 | label-value distance 10 tokens; unit % compatible | 0 | no structured table mapping available | FY2020 | not specified | tomers $1.71b total COVID financial support since 2020 $6.6b total claims paid Medibank journey NPS 12.9 (+2.3) average ahm service NPS 48.0 (+2.0) average customer advocacy +27.9k (+1.4%) net resident policyholder growth +10.5k (+3.1%) net | period-over-period wording in extracted filing/report phrase | supportive | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:018 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| capital_adequacy | dividend Medibank’s capital management objective is to maintain a strong financial risk profile and capacity to pay all eligible customer benefits, invest in the growth of our busi | 250 | $m | capital adequacy near $250 m | value_extracted | 96 | label-value distance 2 tokens; unit $m compatible | 0 | no structured table mapping available | FY2023 | FY2022 | • In June 2023 APRA announced an additional capital adequacy requirement of $250 million for Medibank, with effect from 1 July 2023, following a review of the 2022 cybercrime event. | metric mentioned without explicit comparative baseline | neutral | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:019 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| operating_profit_or_margin | advocacy (eNPS) 3,956 employees including 964 health professionals Financial $618.7m (+8.5%) Group underlying net profit after tax 10.2 cps final ordinary dividend fully franked 26 | 741.5 | $m | operating profit near $741.5m | value_extracted | 92 | label-value distance 4 tokens; unit $m compatible | 0 | no structured table mapping available | not specified | not specified | advocacy (eNPS) 3,956 employees including 964 health professionals Financial $618.7m (+8.5%) Group underlying net profit after tax 10.2 cps final ordinary dividend fully franked 26.5% resident policyholder market share $76.7m (+27.0%) Medib | metric mentioned without explicit comparative baseline | neutral | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:020 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |

## Debate Outcome Scorecard
| Field | Outcome |
|---|---|
| Bull evidence quality | medium |
| Bear evidence quality | high |
| Strongest Bull evidence ID | financial:MPL.AX:2026-07-02:001 |
| Strongest Bear evidence ID | fundamentals:MPL.AX:2026-07-02:001 |
| Which side directly answered the other side better? | Bear |
| Which side relied on weaker or duplicated evidence? | Bull relied more on continuation evidence than confirmed downside falsification |
| Which evidence gap matters most? | Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-02:001, and medium-confidence extraction depth. |
| Debate winner | Bear |
| Rating implication | Underweight |
| Trader implication | timing-gated HOLD |

## Debate Change Assessment
- Pre-debate analyst evidence rating: Underweight.
- Changed by debate? No.
- Explanation: Pre-debate analyst evidence was adverse; debate confirmed Bear evidence quality without turning the research rating into an automatic Sell action.
- Scorecard ID: debate:MPL.AX:2026-07-02:outcome-scorecard

## Market Technicals as Confidence / Timing Modifier
Market setup is a confidence/timing modifier only: latest close 4.99 is above the 10 EMA (4.94), above the 50 SMA (4.77), and above the 200 SMA (4.63). Trend score +2 changes Trader timing and Research Manager confidence, but it is not the evidence winner.

## Evidence Gaps
- No final investment judgment is made by Python. This recommendation is Codex interpretation of collected evidence.
- Social reaction is low confidence and cannot independently drive the rating.

## Risk Management Team Debate

### Aggressive Risk Analyst Round 1 - Opportunity Case

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\4_risk\aggressive_round_1.md`

## Tool Outputs Used
- Bull case evidence: financial:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:008, news:MPL.AX:2026-07-02:001.
- Market reference: market:MPL.AX:2026-07-02:001.

## Opportunity Case
- Upside driver: available ASX filing sections and market evidence support a reviewable base case, supported by financial:MPL.AX:2026-07-02:001 and financial:MPL.AX:2026-07-02:008.
- If price confirms above 5.04, the paper-study setup would have stronger momentum support.

## Failure Points
- Failure point: break below 4.94 or deterioration below the 200 SMA at 4.63.
- Failure point: earnings or segment evidence no longer supports the bull thesis.

## Response To Prior Risk Arguments
The aggressive view accepts that social evidence is low confidence and does not use it as independent confirmation.

### Conservative Risk Analyst Round 1 - Response to Aggressive

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\4_risk\conservative_round_1.md`

## Tool Outputs Used
- Bear case evidence: market:MPL.AX:2026-07-02:006, fundamentals:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:012.
- Financial extraction gaps: commitments/capex sections where unavailable.

## Downside Case
- Downside driver: source coverage gaps and technical confirmation risk limit conviction, supported by market and risk-factor evidence.
- If price loses 4.94, the risk case becomes more important for portfolio sizing.

## Unsupported Upside Challenges
- Unsupported upside challenge: retail bullish labels and low-reasoning posts cannot justify high confidence.
- Unsupported upside challenge: capex/commitment detail is gap-labelled if not extracted, so claims in that area must stay cautious.

## Response To Aggressive
Aggressive has a valid upside case, but it needs trend confirmation and cannot lean on duplicated news/social evidence.

### Neutral Risk Analyst Round 1 - Weighing

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\4_risk\neutral_round_1.md`

## Tool Outputs Used
- Aggressive and Conservative risk rounds.
- Market, financial, and sentiment evidence: market:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:001, social:MPL.AX:2026-07-02:001.

## Risk Argument Quality
- Aggressive evidence quality: medium, because it uses direct financial and news evidence but requires confirmation.
- Conservative evidence quality: medium, because it uses market trend and valuation/timing risk with clear falsification levels.
- Sentiment evidence quality: low; retail-only, noisy, and not decision-grade alone.

## Stronger Risk Side
Stronger risk side: Neutral Risk was stronger because research direction exists, but Trader confirmation gates keep action at HOLD. The concrete opportunity is health_insurers metric direction mix: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only. supportive examples: membership (supportive, financial:MPL.AX:2026-07-02:018); adverse examples: premium growth (adverse, financial:MPL.AX:2026-07-02:016); claims ratio (adverse, financial:MPL.AX:2026-07-02:017); mixed/neutral examples: capital adequacy (neutral, financial:MPL.AX:2026-07-02:019); operating profit (neutral, financial:MPL.AX:2026-07-02:020). Highlighted metric: membership is available / supportive via financial:MPL.AX:2026-07-02:018. This is the strongest concrete opportunity because it is tied to Financial Report Analyst evidence financial:MPL.AX:2026-07-02:018 rather than generic sector language. The concrete risk is Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-02:001, and medium-confidence extraction depth. Market timing risk is explicit at close 4.99 versus confirmation 5.04 and invalidation/caution 4.94.

## Evidence Gaps
- No options-implied risk, borrow/short-interest feed, or intraday volatility surface was available.

### Portfolio Manager Synthesis

- Full output: `codex_tradingagents_skillkit\runs\asx_2026-07-02_closed_loop\reports\MPL.AX\2026-07-02\5_portfolio\decision.md`

## Tool Outputs Used
- Research Manager: Underweight.
- Trader action: HOLD at reference price 4.99.
- Risk debate outputs and evidence: market:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:001, news:MPL.AX:2026-07-02:001.

## Risk debate impact
The risk debate tempers position implementation through concrete evidence, not a generic sizing phrase. Strongest concrete opportunity: health_insurers metric direction mix: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only. supportive examples: membership (supportive, financial:MPL.AX:2026-07-02:018); adverse examples: premium growth (adverse, financial:MPL.AX:2026-07-02:016); claims ratio (adverse, financial:MPL.AX:2026-07-02:017); mixed/neutral examples: capital adequacy (neutral, financial:MPL.AX:2026-07-02:019); operating profit (neutral, financial:MPL.AX:2026-07-02:020). Highlighted metric: membership is available / supportive via financial:MPL.AX:2026-07-02:018. This is the strongest concrete opportunity because it is tied to Financial Report Analyst evidence financial:MPL.AX:2026-07-02:018 rather than generic sector language. Strongest concrete risk: Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-02:001, and medium-confidence extraction depth. Market timing risk is explicit at close 4.99 versus confirmation 5.04 and invalidation/caution 4.94. Stronger risk side: Neutral Risk was stronger because research direction exists, but Trader confirmation gates keep action at HOLD.

## Final Portfolio Decision
**Rating**: Underweight

Research decision: Underweight. Trader action: HOLD. Portfolio decision: maintain Underweight paper-study stance while preserving rating/action tension. Rating and action differ because research evidence supports the rating, but setup quality does not yet justify action. No real trade execution or broker/order tooling is used.

## Rating-Action Tension
- Research Manager rating: Underweight
- Trader action: HOLD
- Portfolio stance: Underweight
- Interpretation: research evidence and trade timing are separate decisions; the portfolio stance reflects research quality and risk debate, not just the immediate Trader action.

## Evidence Gaps
- Portfolio sizing, tax constraints, mandate constraints, and liquidity limits are not modeled.

## Transcript Integrity

- Pending debate outputs: `0`
- The complete report should cite these same role outputs rather than treating this file as a separate evidence source.
